GEN has its new list of hubs that are “hot spots” for biotech jobs, and while there’s no ranking of the hubs, San Diego (along with the other Big3Bio regions) is highlighted as one of the top in the country.
From GEN/Editor Alex Philippidis:
“GEN generated its list of the top 10 U.S. regions in which to secure a biotech job by identifying the areas most frequently cited in biotechnology and pharmaceutical job listings. Over the past month, GEN collected data by scrutinizing five employment websites—LinkedIn, Bio-Space, Medzilla, Indeed, and Monster.
San Francisco Bay Area
The brand-new 2016 California Life Sciences Industry Report, released November 12, featured the Bay Area in its all-too-familiar role as the leading region within the Golden State, accounting for 23% (63,907) of the industry’s 281,198 jobs statewide. San Francisco and vicinity constitute the nation’s oldest cluster, and the largest on the West Coast. Home-grown biopharmas continue to go public, with two companies launching IPOs (CytomX and MyoKardia) since late September when the market began to sour on biotech. The region can also boast of the most recent (at deadline) home-grown company to get bought by a pharma giant, as ZS Pharma of San Mateo, CA, earlier this month agreed to be acquired by AstraZeneca for $2.7 billion. Within the East Bay, Aduro Biotech—which raised $124.3 million net through an IPO on April 20—disclosed plans to more-than-double its workforce from 80 to 200 people by mid-2016, when it is set to move into a new building at Aquatic Park in Berkeley. But the biopharma news is not all good for the region: Amgen axed 300 employees at Onyx Pharmaceuticals, which it acquired for $10.4 billion in 2013. And KaloBios earlier this month shed 17 jobs—61% of its total workforce—following a series of clinical trial disappointments.”